Drug intelligence / Profile preview

2-(4-(2-((3-(5-(pyridin-2-ylthio)thiazol-2-yl)ureido)methyl)-1H-imidazol-4-yl)phenoxy)acetic acid

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule with the chemical formula C21H18N6O4S₂ and a molecular weight of approximately 482.5 g/mol[1][5]. It is also known as "CHEMBL1206212" and "2PTUM-IPAA"[7]. The structure features a thiazole, imidazole, phenoxy, and acetic acid moiety connected via urea and thioether linkages. It is classified as an experimental drug with no approved indications or clinical trial activity reported to date[1][3][6]. Its mechanism of action has not been characterized in public databases such as DrugBank or PubChem; it may have been synthesized for research purposes related to amide derivatives or enzyme inhibition but lacks published pharmacological data[6].

Other names
2PTUM-IPAACHEMBL1206212CHEMBL-1206212CHEMBL 12062122-(4-{2-[({[5-(pyridin‑2‑ylsulfanyl)-1,3-thiazol‑2‑yl]carbamoyl}amino)methyl]-1H-imidazol‑4‑yl}phenoxy)acetic acid

Beyond the preview

Go deeper on 2-(4-(2-((3-(5-(pyridin-2-ylthio)thiazol-2-yl)ureido)methyl)-1H-imidazol-4-yl)phenoxy)acetic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-(4-(2-((3-(5-(pyridin-2-ylthio)thiazol-2-yl)ureido)methyl)-1H-imidazol-4-yl)phenoxy)acetic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call